NIH AIDS Council Goes Virtual for Research Chat
Published Date: 5/22/2025
Notice
Summary
The Office of AIDS Research Advisory Council is holding a virtual meeting on June 26, 2025, to share updates on HIV research plans and priorities. Anyone interested can watch online or send in comments ahead of time. This meeting affects researchers, healthcare professionals, and the public who care about HIV research progress and funding.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Virtual Public Meeting on HIV Research
The Office of AIDS Research Advisory Council will hold a virtual, public meeting on June 26, 2025, from 12:00 p.m. to 4:00 p.m. You can watch the meeting online via the NIH Videocast at https://videocast.nih.gov/.
Opportunity To Submit Written Comments
Anyone interested may file written comments with the committee before the meeting by sending a statement to the listed Contact Person. Your statement should include your name, address, telephone number, and, if applicable, your business or professional affiliation.
Accommodations Available for Viewing
If you need special assistance or other reasonable accommodations to view the virtual meeting, you should notify the Contact Person listed in advance. The Contact Person can be reached at (301) 496-0357 or the Office of AIDS Research address provided in the notice.
Agenda: NIH Strategic Plan and HIV Priorities
The meeting agenda includes a report from the OAR Director and an update on development of the NIH Strategic Plan and research priorities for HIV research. Researchers, health care professionals, and members of the public interested in HIV research plans and priorities may find the update relevant.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
Previous / Next Documents
Previous: 2025-09187, Self-Regulatory Organizations; Cboe EDGA Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Increase the Monthly Fee for 10 Gb Physical Ports
Cboe EDGA Exchange is raising the monthly fee for its 10 Gb physical ports, which traders and firms use to connect to the exchange. This change means users will pay more starting right away, helping the exchange cover costs and improve services. If you rely on these ports, get ready for a slightly bigger bill each month!
Next: 2025-09189, Information Collection; General Services Administration Acquisition Regulation; Construction-Manager-as-Constructor Contracting
The General Services Administration (GSA) is asking for public feedback to extend a paperwork rule about Construction-Manager-as-Constructor contracts. This affects companies and workers involved in government construction projects, helping keep things clear and organized. No big changes in costs or timing are expected, but your input helps keep the process smooth and fair!